Annual EBITDA:
-$183.47M+$190.33M(+50.92%)Summary
- As of today, NVAX annual EBITDA is -$183.47 million, with the most recent change of +$190.33 million (+50.92%) on December 31, 2024.
- During the last 3 years, NVAX annual EBITDA has risen by +$1.49 billion (+89.04%).
- NVAX annual EBITDA is now -4285.13% below its all-time high of -$4.18 million, reached on December 31, 1999.
Performance
NVAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$72.82M-$186.05M(-164.31%)Summary
- As of today, NVAX quarterly EBITDA is -$72.82 million, with the most recent change of -$186.05 million (-164.31%) on September 30, 2025.
- Over the past year, NVAX quarterly EBITDA has increased by +$44.26 million (+37.80%).
- NVAX quarterly EBITDA is now -113.89% below its all-time high of $524.36 million, reached on March 31, 2025.
Performance
NVAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$451.74M+$44.26M(+10.86%)Summary
- As of today, NVAX TTM EBITDA is $451.74 million, with the most recent change of +$44.26 million (+10.86%) on September 30, 2025.
- Over the past year, NVAX TTM EBITDA has increased by +$694.92 million (+285.76%).
- NVAX TTM EBITDA is now -3.37% below its all-time high of $467.50 million, reached on March 31, 2025.
Performance
NVAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NVAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +50.9% | +37.8% | +285.8% |
| 3Y3 Years | +89.0% | +38.7% | +137.6% |
| 5Y5 Years | -48.2% | +62.1% | +276.5% |
NVAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +89.0% | -113.9% | +76.0% | -3.4% | +137.6% |
| 5Y | 5-Year | -48.2% | +89.0% | -113.9% | +91.1% | -3.4% | +127.0% |
| All-Time | All-Time | -4285.1% | +89.0% | -113.9% | +91.1% | -3.4% | +127.0% |
NVAX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$72.82M(-164.3%) | $451.74M(+10.9%) |
| Jun 2025 | - | $113.23M(-78.4%) | $407.48M(-12.8%) |
| Mar 2025 | - | $524.36M(+563.9%) | $467.50M(+354.8%) |
| Dec 2024 | -$183.47M(+50.9%) | -$113.04M(+3.4%) | -$183.44M(+24.6%) |
| Sep 2024 | - | -$117.07M(-167.6%) | -$243.18M(-1.1%) |
| Jun 2024 | - | $173.25M(+236.9%) | -$240.56M(+27.9%) |
| Mar 2024 | - | -$126.58M(+26.7%) | -$333.56M(+34.7%) |
| Dec 2023 | -$373.80M(+39.3%) | -$172.77M(-51.0%) | -$510.70M(+11.0%) |
| Sep 2023 | - | -$114.45M(-242.6%) | -$573.99M(+0.8%) |
| Jun 2023 | - | $80.25M(+126.4%) | -$578.38M(+49.0%) |
| Mar 2023 | - | -$303.73M(-28.7%) | -$1.13B(-84.5%) |
| Dec 2022 | -$615.68M(+63.2%) | -$236.06M(-98.6%) | -$615.08M(+48.8%) |
| Sep 2022 | - | -$118.84M(+75.0%) | -$1.20B(+13.3%) |
| Jun 2022 | - | -$476.24M(-320.4%) | -$1.38B(-10.6%) |
| Mar 2022 | - | $216.06M(+126.3%) | -$1.25B(+25.2%) |
| Dec 2021 | -$1.67B(-309.1%) | -$821.30M(-171.2%) | -$1.67B(-61.9%) |
| Sep 2021 | - | -$302.88M(+11.8%) | -$1.03B(-12.0%) |
| Jun 2021 | - | -$343.42M(-66.5%) | -$922.85M(-55.5%) |
| Mar 2021 | - | -$206.31M(-13.9%) | -$593.58M(-45.0%) |
| Dec 2020 | -$409.13M(-230.5%) | -$181.06M(+5.7%) | -$409.23M(-59.9%) |
| Sep 2020 | - | -$192.06M(-1257.6%) | -$255.95M(-194.1%) |
| Jun 2020 | - | -$14.15M(+35.6%) | -$87.02M(+19.1%) |
| Mar 2020 | - | -$21.97M(+20.9%) | -$107.61M(+13.2%) |
| Dec 2019 | -$123.80M(+25.3%) | -$27.77M(-20.1%) | -$123.92M(+11.9%) |
| Sep 2019 | - | -$23.12M(+33.4%) | -$140.68M(+10.6%) |
| Jun 2019 | - | -$34.74M(+9.3%) | -$157.41M(+3.2%) |
| Mar 2019 | - | -$38.28M(+14.0%) | -$162.61M(+1.9%) |
| Dec 2018 | -$165.76M(-2.4%) | -$44.53M(-11.7%) | -$165.76M(+0.7%) |
| Sep 2018 | - | -$39.86M(+0.2%) | -$166.89M(-1.1%) |
| Jun 2018 | - | -$39.94M(+3.6%) | -$165.13M(-0.3%) |
| Mar 2018 | - | -$41.43M(+9.3%) | -$164.61M(-1.7%) |
| Dec 2017 | -$161.89M(+37.9%) | -$45.66M(-19.9%) | -$161.89M(+3.7%) |
| Sep 2017 | - | -$38.10M(+3.3%) | -$168.06M(+12.0%) |
| Jun 2017 | - | -$39.41M(-1.8%) | -$191.04M(+15.5%) |
| Mar 2017 | - | -$38.72M(+25.3%) | -$226.01M(+13.3%) |
| Dec 2016 | -$260.61M(-72.3%) | -$51.83M(+15.2%) | -$260.61M(+8.9%) |
| Sep 2016 | - | -$61.09M(+17.9%) | -$286.05M(-11.5%) |
| Jun 2016 | - | -$74.39M(-1.5%) | -$256.61M(-27.3%) |
| Mar 2016 | - | -$73.31M(+5.1%) | -$201.56M(-33.3%) |
| Dec 2015 | -$151.25M(-90.8%) | -$77.27M(-144.1%) | -$151.25M(-45.1%) |
| Sep 2015 | - | -$31.65M(-63.7%) | -$104.22M(-14.1%) |
| Jun 2015 | - | -$19.34M(+15.9%) | -$91.33M(-2.8%) |
| Mar 2015 | - | -$23.00M(+23.9%) | -$88.86M(-12.1%) |
| Dec 2014 | -$79.27M(-63.3%) | -$30.24M(-61.3%) | -$79.27M(-27.2%) |
| Sep 2014 | - | -$18.75M(-11.1%) | -$62.33M(-9.6%) |
| Jun 2014 | - | -$16.88M(-25.9%) | -$56.88M(-8.6%) |
| Mar 2014 | - | -$13.40M(-0.8%) | -$52.39M(-7.9%) |
| Dec 2013 | -$48.54M(-73.4%) | -$13.30M(+0.0%) | -$48.54M(-9.6%) |
| Sep 2013 | - | -$13.30M(-7.4%) | -$44.29M(-18.3%) |
| Jun 2013 | - | -$12.39M(-29.6%) | -$37.43M(-22.7%) |
| Mar 2013 | - | -$9.56M(-5.6%) | -$30.49M(-8.9%) |
| Dec 2012 | -$28.00M(-40.2%) | -$9.04M(-40.4%) | -$28.00M(-22.8%) |
| Sep 2012 | - | -$6.44M(-18.2%) | -$22.80M(-14.5%) |
| Jun 2012 | - | -$5.45M(+22.9%) | -$19.91M(+0.4%) |
| Mar 2012 | - | -$7.06M(-83.8%) | -$19.99M(-0.1%) |
| Dec 2011 | -$19.97M(+46.2%) | -$3.84M(-8.0%) | -$19.96M(+12.2%) |
| Sep 2011 | - | -$3.56M(+35.5%) | -$22.75M(+22.5%) |
| Jun 2011 | - | -$5.52M(+21.6%) | -$29.37M(+10.9%) |
| Mar 2011 | - | -$7.04M(-6.3%) | -$32.98M(+11.1%) |
| Dec 2010 | -$37.09M | -$6.63M(+34.9%) | -$37.09M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$10.18M(-11.5%) | -$44.33M(-5.3%) |
| Jun 2010 | - | -$9.13M(+18.2%) | -$42.11M(-4.0%) |
| Mar 2010 | - | -$11.16M(+19.5%) | -$40.50M(-11.9%) |
| Dec 2009 | -$36.19M(-8.1%) | -$13.86M(-74.0%) | -$36.19M(-15.9%) |
| Sep 2009 | - | -$7.96M(-5.9%) | -$31.23M(+4.9%) |
| Jun 2009 | - | -$7.52M(-9.9%) | -$32.83M(+1.4%) |
| Mar 2009 | - | -$6.84M(+23.1%) | -$33.30M(+0.5%) |
| Dec 2008 | -$33.47M(-22.4%) | -$8.90M(+7.0%) | -$33.47M(-9.6%) |
| Sep 2008 | - | -$9.56M(-19.7%) | -$30.54M(-3.5%) |
| Jun 2008 | - | -$7.99M(-14.0%) | -$29.50M(+0.0%) |
| Mar 2008 | - | -$7.01M(-17.5%) | -$29.50M(+4.0%) |
| Dec 2007 | -$27.34M(-26.9%) | -$5.97M(+30.1%) | -$30.75M(+8.5%) |
| Sep 2007 | - | -$8.53M(-6.7%) | -$33.60M(-12.0%) |
| Jun 2007 | - | -$7.99M(+3.1%) | -$29.99M(-6.1%) |
| Mar 2007 | - | -$8.25M(+6.4%) | -$28.28M(-16.3%) |
| Dec 2006 | -$21.55M(-33.8%) | -$8.82M(-79.1%) | -$24.31M(-34.0%) |
| Sep 2006 | - | -$4.92M(+21.6%) | -$18.15M(-17.5%) |
| Jun 2006 | - | -$6.28M(-46.4%) | -$15.45M(-14.8%) |
| Mar 2006 | - | -$4.29M(-61.6%) | -$13.46M(+19.2%) |
| Dec 2005 | -$16.11M(+49.4%) | -$2.65M(-19.4%) | -$16.66M(+27.6%) |
| Sep 2005 | - | -$2.22M(+48.2%) | -$23.02M(+26.8%) |
| Jun 2005 | - | -$4.29M(+42.7%) | -$31.47M(+6.9%) |
| Mar 2005 | - | -$7.49M(+16.9%) | -$33.81M(-10.6%) |
| Dec 2004 | -$31.85M(-114.2%) | -$9.02M(+15.5%) | -$30.57M(-25.8%) |
| Sep 2004 | - | -$10.67M(-60.9%) | -$24.30M(-49.3%) |
| Jun 2004 | - | -$6.63M(-56.1%) | -$16.28M(-16.3%) |
| Mar 2004 | - | -$4.25M(-54.6%) | -$13.99M(+5.9%) |
| Dec 2003 | -$14.87M(+27.2%) | -$2.75M(-3.7%) | -$14.87M(+11.1%) |
| Sep 2003 | - | -$2.65M(+39.1%) | -$16.73M(+16.9%) |
| Jun 2003 | - | -$4.35M(+15.1%) | -$20.14M(+2.9%) |
| Mar 2003 | - | -$5.12M(-11.1%) | -$20.74M(-1.6%) |
| Dec 2002 | -$20.42M(-106.5%) | -$4.61M(+23.9%) | -$20.42M(+7.5%) |
| Sep 2002 | - | -$6.06M(-22.3%) | -$22.07M(-25.9%) |
| Jun 2002 | - | -$4.95M(-3.3%) | -$17.53M(-31.6%) |
| Mar 2002 | - | -$4.80M(+23.4%) | -$13.32M(-34.7%) |
| Dec 2001 | -$9.89M(+18.6%) | -$6.26M(-313.9%) | -$9.89M(-17.4%) |
| Sep 2001 | - | -$1.51M(-102.5%) | -$8.43M(+17.3%) |
| Jun 2001 | - | -$747.00K(+45.4%) | -$10.19M(+16.2%) |
| Mar 2001 | - | -$1.37M(+71.5%) | -$12.16M(-0.1%) |
| Dec 2000 | -$12.15M(-190.3%) | -$4.80M(-46.6%) | -$12.15M(-48.0%) |
| Sep 2000 | - | -$3.27M(-20.2%) | -$8.21M(-24.3%) |
| Jun 2000 | - | -$2.72M(-101.3%) | -$6.60M(-40.0%) |
| Mar 2000 | - | -$1.35M(-57.3%) | -$4.72M(-12.8%) |
| Dec 1999 | -$4.18M(+14.1%) | -$860.00K(+48.4%) | -$4.18M(+14.7%) |
| Sep 1999 | - | -$1.67M(-99.3%) | -$4.90M(-10.1%) |
| Jun 1999 | - | -$837.00K(-2.2%) | -$4.45M(+7.8%) |
| Mar 1999 | - | -$819.00K(+48.1%) | -$4.83M(+0.8%) |
| Dec 1998 | -$4.87M(-7.3%) | -$1.58M(-29.4%) | -$4.87M(-13.5%) |
| Sep 1998 | - | -$1.22M(-0.6%) | -$4.29M(-2.9%) |
| Jun 1998 | - | -$1.21M(-41.0%) | -$4.17M(+2.1%) |
| Mar 1998 | - | -$859.70K(+14.0%) | -$4.26M(+3.2%) |
| Dec 1997 | -$4.54M(+12.8%) | -$1.00M(+9.1%) | -$4.40M(+13.7%) |
| Sep 1997 | - | -$1.10M(+15.4%) | -$5.10M(-4.1%) |
| Jun 1997 | - | -$1.30M(-30.0%) | -$4.90M(-2.1%) |
| Mar 1997 | - | -$1.00M(+41.2%) | -$4.80M(0.0%) |
| Dec 1996 | -$5.21M(+19.6%) | -$1.70M(-88.9%) | -$4.80M(-54.8%) |
| Sep 1996 | - | -$900.00K(+25.0%) | -$3.10M(-40.9%) |
| Jun 1996 | - | -$1.20M(-20.0%) | -$2.20M(-120.0%) |
| Mar 1996 | - | -$1.00M | -$1.00M |
| Dec 1995 | -$6.47M | - | - |
FAQ
- What is Novavax, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Novavax, Inc.?
- What is Novavax, Inc. annual EBITDA year-on-year change?
- What is Novavax, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Novavax, Inc.?
- What is Novavax, Inc. quarterly EBITDA year-on-year change?
- What is Novavax, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Novavax, Inc.?
- What is Novavax, Inc. TTM EBITDA year-on-year change?
What is Novavax, Inc. annual EBITDA?
The current annual EBITDA of NVAX is -$183.47M
What is the all-time high annual EBITDA for Novavax, Inc.?
Novavax, Inc. all-time high annual EBITDA is -$4.18M
What is Novavax, Inc. annual EBITDA year-on-year change?
Over the past year, NVAX annual EBITDA has changed by +$190.33M (+50.92%)
What is Novavax, Inc. quarterly EBITDA?
The current quarterly EBITDA of NVAX is -$72.82M
What is the all-time high quarterly EBITDA for Novavax, Inc.?
Novavax, Inc. all-time high quarterly EBITDA is $524.36M
What is Novavax, Inc. quarterly EBITDA year-on-year change?
Over the past year, NVAX quarterly EBITDA has changed by +$44.26M (+37.80%)
What is Novavax, Inc. TTM EBITDA?
The current TTM EBITDA of NVAX is $451.74M
What is the all-time high TTM EBITDA for Novavax, Inc.?
Novavax, Inc. all-time high TTM EBITDA is $467.50M
What is Novavax, Inc. TTM EBITDA year-on-year change?
Over the past year, NVAX TTM EBITDA has changed by +$694.92M (+285.76%)